Enalare Therapeutics Inc.
Pharmaceutical company · Princeton, New Jersey, United States
Enalare Therapeutics Inc. is a pharmaceutical company headquartered in Princeton, New Jersey, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2022.
Enalare Therapeutics at a glance
What does Enalare Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2022 to 2025). NIH funding came from the National Institute on Drug Abuse.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $12.5 million sold (2022).
Frequently asked questions about Enalare Therapeutics
Where is Enalare Therapeutics headquartered?
Enalare Therapeutics Inc. is headquartered in Princeton, New Jersey, United States.
What does Enalare Therapeutics do?
Enalare Therapeutics Inc. is a pharmaceutical company.
When was Enalare Therapeutics founded?
The earliest incorporation on record for Enalare Therapeutics Inc. is in 2018, according to public company registers.
Similar companies
- Soligenix, Inc.Princeton, New Jersey, United States
- PDS Biotechnology CorpPrinceton, New Jersey, United States
- Amicus Therapeutics, Inc.Princeton, New Jersey, United States
- Bristol Myers Squibb CoPrinceton, New Jersey, United States
- Grace Therapeutics, Inc.Princeton, New Jersey, United States
- PMV Pharmaceuticals, Inc.Princeton, New Jersey, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.